Edition:
United States

People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

39.92USD
19 Sep 2017
Change (% chg)

-- (--)
Prev Close
$39.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,832,966
52-wk High
$44.53
52-wk Low
$37.20

Hampton, Philip 

Sir Philip Hampton is Non-Executive Chairman of the Board of GlaxoSmithKline PLC., effective May 7, 2015. Prior to joining GSK, Sir Philip chaired major FTSE 100 companies including The Royal Bank of Scotland Group plc and J Sainsbury plc. He has also served as Group Finance Director at Lloyds TSB Group, BT Group plc, BG Group plc, British Gas and British Steel plc. Sir Philip was previously appointed an Executive Director of Lazards and a Non-Executive Director at RMC Group Plc and Belgacom SA. Until 2009, he was Chairman of UK Financial Investments Limited, which manages the UK Government’s shareholdings in banks. External appointments Sir Philip is currently the Senior Independent Director of Anglo American Plc, Chairman of its Remuneration Committee and member of its Audit Committee. Sir Philip is also Chair of the Women on Board’s review; an independent review on increasing representation of women in the executive level of FTSE 350 companies.

Basic Compensation

Total Annual Compensation, GBP 519,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 3,000
Fiscal Year Total, GBP 522,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --